New #VerilyNof1 release! Eye on the Future 👁️ Set in a small Texas community with one of the highest rates of diabetes in the nation, historically it has been medically underserved. Watch how Superior Health and Verily provide diabetes patients Armando and Norma with quality retinal screenings to close gaps in access and care. "N of 1" is a docuseries about Verily customers and partners using diverse data sources for a holistic understanding of patient health. Learn about Verily Numetric Retinal Service: https://veri.ly/4g66d8B #DiabetesManagement #diabetes #HealthEquity #PrecisionHealth
Verily
Hospitals and Health Care
Dallas, Texas 164,752 followers
We are an Alphabet company bringing the promise of precision health to everyone, every day.
About us
Verily is an Alphabet company combining a data-driven, people-first approach to bring the promise of precision health to everyone, every day. We are focused on generating and applying evidence from a wide variety of sources to change the way people manage their health and the way healthcare is delivered - shifting the paradigm from “one size fits all” medicine to one focused on a more comprehensive view of the individual that leads to a more personalized path forward. For more information, please visit verily.com. Verily is hiring! Check out what's available globally at verily.com/careers.
- Website
-
http://www.verily.com
External link for Verily
- Industry
- Hospitals and Health Care
- Company size
- 1,001-5,000 employees
- Headquarters
- Dallas, Texas
- Type
- Privately Held
- Founded
- 2015
- Specialties
- healthcare, hardware, software, clinical studies, scientific research, disease management platforms, sensors, population health management, precision medicine, precision health, health equity, digital health, and health tech
Locations
Employees at Verily
Updates
-
The use of digital health technologies (DHTs) in registries has the potential to improve evidence generation by reflecting real-world patient-centered outcomes. However, there are challenges to implementing DHTs, which has prevented broad adoption. Click through below to learn what some of them are, along with proposed solutions. The details, outlined in a paper published in The Lancet Digital Health, are based on the collective experiences of co-authors* representing the Health Data Research UK (HDR UK), Verily and the patient community. https://veri.ly/4fkuh6a #DigitalHealth #wearables #ClinicalStudies *Caroline Marra, PhD, Tim Chico, MD, April Inyard Alexandrow, PhD, Will G Dixon, PhD, Norman Briffa, MD, Erin Rainaldi, MS, Max A. Little, PhD, Kristin Size, Athanasios Tsanas, PhD, Joe Franklin, JD, PhD, Ritu Kapur, Ph.D., Helen Grice, Anwar Gariban, Joy Ellery, Cathie Sudlow, Amy Abernethy, MD, PhD, Andrew Morris, MD, FCRP
-
We are excited to see the launch of Digital Medicine Society (DiMe)’s new framework for validating novel digital clinical measures! Adopting these resources will not only enhance the quality and effectiveness of sensor-based digital health technologies evaluation but also lead to significant improvements in patient care and health outcomes. At Verily, we are committed to generating patient-centered digital measures of health into meaningful, real-world evidence for accelerating research and development. https://veri.ly/3DhWnBV #DigitalHealth #wearables #HealthcareInnovation
📣 Announcing new resources to transform #digitalhealth innovation! Today, during a public launch event, we were thrilled to announce new resources to accelerate the adoption of novel digital clinical measures. 🔍 Digital clinical measures that are meaningful to patients are revolutionizing how we evaluate health. Yet, some of the greatest value associated with digital endpoints remains out of reach. This is especially true for novel digital clinical measures that capture symptoms of disease that have never been measured before. 💡 DATAcc has developed the Validating Novel Digital Clinical Measures resources for DHT developers, biostatisticians, and regulators. Adopting these resources in your work will unlock the full potential of novel digital clinical measures for scientific and clinical decision-making, ultimately for new therapies to reach patients. These resources will accelerate the adoption of digital endpoints in clinical research and related regulatory interactions. By using these resources, you can: ▪️ Establish your study objectives and context of use ▪️ Select rigorous and fit-for-purpose reference measures ▪️ Assess the effect of your intended use environment ▪️ Consider when and how to engage regulators ▪️ Design a rigorous analytical validation study for your digital clinical measure of interest ▪️ Use the workbook format to document your study plan ▪️ Present your study plan and results to regulators and other stakeholders 👉 Ready to take the next step? Access these tools today: https://bit.ly/3VvBPfo
-
-
What advances in healthcare will make an impact in 2025? Find out in a new report from Onyx and published in Fortune. 36 healthcare CEOs, including our own Stephen Gillett, share what they’re working on and their top priorities in the coming year. https://veri.ly/4g0pPL0 #PrecisionHealth #HealthTech #HealthcareInnovation
-
A single sample of wastewater = incredible insights into what pathogens are present in a community and at what levels. Watch how Verily is turning water into wisdom: https://bit.ly/3D12r1G #VerilyNof1 #wastewater #PublicHealth #HealthcareInnovation
-
Congratulations to Dr. Robert Califf on this well-deserved Pioneer Award from the PMWC - Precision Medicine World Conference 👏 We look forward to the event in February where Verily Chief Medical and Scientific Officer Andrew Trister, MD PhD will be moderating a panel on AI-powered real-world evidence. Plus, our Head of Data Science for Devices Erin Rainaldi will talk about the use of digital measures to track physical activity changes in people with early-stage Parkinson's Disease. https://bit.ly/4g7EzaF
Co-founder & President, PMWC Intl / 33,000 LI Followers / PMWC Newsletters 92,000+ subscribers since 2009- SORRY, UNABLE TO ACCEPT MORE CONNECTIONS DUE TO THE LINKEDIN LIMIT
Saluting and Honoring Dr. Robert Califf’s Visionary Leadership in Innovation and Healthcare at PMWC 2025 (Feb. 5-7). Dr. Robert Califf, the 25th Commissioner of the FDA and a distinguished leader in healthcare innovation, will be honored at PMWC 2025 with the prestigious Pioneer Award. Before resuming his role at the FDA, Dr. Califf served as Chief Medical Officer at Verily, where he spearheaded groundbreaking initiatives in precision health and data-driven healthcare solutions. His leadership at Verily highlighted his dedication to advancing patient care through technological innovation. At PMWC 2025, we celebrate Dr. Califf for his transformative contributions, which include: --Pioneering AI-Driven Regulatory Guidance: Developing guidelines for the safe and effective use of AI in drug manufacturing. --Modernizing Regulatory Frameworks: Adapting FDA regulations to keep pace with rapid technological advancements. --Fostering Innovation: Encouraging the development of innovative medical products while ensuring patient safety. His work exemplifies a balance between fostering innovation and maintaining rigorous safety standards, ensuring that advancements in healthcare delivery are both groundbreaking and secure. Following the award ceremony on February 5th, join us for an exclusive fireside chat with Dr. Califf, Keith R. Yamamoto, and Kathy Giacomini, UCSF. This engaging discussion will delve into the future of healthcare innovation, AI applications, and regulatory advancements shaping the industry. Don’t miss this opportunity to celebrate and learn from one of the most influential leaders in healthcare. Join us in congratulating him: Duke University, Duke Clinical Research Institute, RALPH SNYDERMAN, M.D.. Geoffrey Ginsburg, Susan Winckler, Reagan-Udall Foundation for the FDA, Mei Sheng Duh, RPh, MPH, ScD, Analysis Group, Rachael Fones, Sheila D. Walcoff, JD. Critical Path Institute (C-Path), Ida Sim, Sharat Israni, Erin Rainaldi, Andrew Trister, MD PhD, Charles Gersbach, Susan Lynch, Olivier Gevaert, Michelle Arkin, , Advanced Research Projects Agency for Health (ARPA-H), Chuck Romine, National Institute of Standards and Technology (NIST), Erwin Gianchandani, National Science Foundation (NSF), Nooshin Navidi Latour Sam Sinai, Dyno Therapeutics, Namrata A., Diffuse Bio, Rishi Bedi, Y-Trap Jianying Hu, IBM, Portola Pharmaceuticals, Regado BioSciences, Inc., PMWC - Precision Medicine World Conference See Track 4 Feb. 5th: https://lnkd.in/gPtkWZbQ
-
-
Marti Fernandes, BS, EP is a dedicated Verily health coach who helps our care solution members with diabetes thrive. We asked her about her role and how she supports them: “I walk alongside our members on their path to overcoming all types of challenges that they face in achieving their personal health goals. I’m equipped to make suggestions on daily living and wellness with diabetes." Learn more about Marti’s passion for making a difference in diabetes care: https://bit.ly/4ePTMvS #DiabetesManagement #DiabetesAwarenessMonth #VirtualCare #DiabetesAwareness
-
-
This Diabetes Awareness Month, take charge of your health. Prevent diabetes-related complications with yearly screenings for diabetic retinopathy, a leading cause of blindness. Verily Numetric Retinal Service expands access to quality eye care, helping people like Armando, who was asymptomatic yet diagnosed with diabetic retinopathy through the service. Stay tuned for Armando’s story, which takes place in Donna, Texas on our next #VerilyNof1 docuseries episode! Swipe for a preview. https://bit.ly/4g5R1aV #DiabeticRetinopathy #DiabetesAwareness #DiabetesManagement #PrecisionHealth
-
From operations adviser in 2020 to Chairman and CEO in 2023, Stephen Gillett is leading Verily’s mission to bring the promise of precision health to everyone, every day. In an interview with Adil Ali, MD he shares his career journey that led him to Verily, thoughts on the potential for AI in healthcare, and the overall vision for our platform and solutions. Read more in the Q&A, produced by Onyx and to be published in Fortune: https://bit.ly/3ZoDK7K #PrecisionHealth #HealthTech #HealthcareInnovation
-